RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
  AIDS
  Anthrax
  Dengue
  Ebola
  HCV
  Influenza
  Leishmaniasis
  Malaria
  MRSA
  Mumps
  Pertussis
  Prion Diseases
  SARS
  Shigella
  Small Pox
  Tuberculosis
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Jan 9, 2010 - 5:55:44 PM
AIDS Channel

subscribe to AIDS newsletter
Latest Research : Infectious Diseases : AIDS

   EMAIL   |   PRINT
Key protein found that helps HIV assault brain

Nov 16, 2008 - 3:26:04 PM
Scientists have observed that a large percentage of HIV patients - perhaps up to half - show evidence of neurologic disease from the virus.

 
[RxPG] Washington, Nov 15 - Researchers have isolated a key protein that explains why antiviral drugs can fend off the HIV in the body, but not in the brain.


The new study traces how key steps taken by Tat, a protein that helps HIV operate, replicate and infect cells, enables HIV to attack the brain, bringing about severe inflammation.

Researchers identified the receptor that Tat uses to attack neurons, whose effects they reversed by blocking the receptor.

'Suddenly the brain environment turns from nurturing to toxic. Cells are on overdrive, spending a lot more energy to do the same things they used to do easily,' said Harris Gelbard, neurologist at Rochester University Medical Centre.

'The current medications give many patients a new lease on life. But the virus is still taking a toll on the brain, even when the virus appears to be much less active elsewhere in the body,' said Gelbard, the paper's co-author.

The discovery of a major molecular player in the process opens up new ways of exploring how to prevent or treat HIV's neurological effects, for which there is no currently approved treatment, said a Rochester release.

Much of the molecular action that underlies HIV's attack on the brain also occurs in other diseases, such as Parkinson's and Alzheimer's diseases, and the results spell progress for those conditions as well.

The powerful antiviral drugs that keep many HIV patients healthy for years don't completely eradicate the virus from the body, and in the brain, even the very low levels of that remain cause relentless damage.

Scientists have observed that a large percentage of HIV patients - perhaps up to half - show evidence of neurologic disease from the virus.

These findings were published online in the Nov 13 issue of PloS One.






Related AIDS News
U of M scientist gets 5-year, $10 million grant to direct innovative HIV research program
New drug regimens cut HIV spread from mother to infant
6-month drug regimen cuts HIV risk for breastfeeding infants, NIH study finds
New vaccine technology protects mice from hepatitis C virus
Study suggests why HIV-uninfected babies of mothers with HIV might be more prone to infections
Broadly-reactive neutralizing antibodies bring scientists closer to HIV vaccine
Fulbright Award has UC educator examining health challenges in China
Surprising AIDS-treatment benefits, prevention strategy in epidemic regions of Africa
30 years on in the epicenter of the African AIDS epidemic
HHS agencies partner with PEPFAR to transform African medical education

Subscribe to AIDS Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

All rights reserved by RxPG
Contact Us